First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 33444578.
- Also identified by DOI 10.1016/j.athoracsur.2020.11.052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.
Medical subject headings
- Cardiac Surgical Procedures
- Heart Failure
- Heart Ventricles
- Heart-Assist Devices
- Ventricular Function, Left
- Ventricular Remodeling